wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39431314-84DB801A-970B-496F-802D-1E26AF2A5F8C
Q39431314-84DB801A-970B-496F-802D-1E26AF2A5F8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39431314-84DB801A-970B-496F-802D-1E26AF2A5F8C
Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval.
P2860
Q39431314-84DB801A-970B-496F-802D-1E26AF2A5F8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39431314-84DB801A-970B-496F-802D-1E26AF2A5F8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
377e5af85e544bd543a6605fb9516e064e2a21d7
P2860
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.